Todos Medical aims to develop and bring to market its revolutionary blood tests for cancer detection.
The Israel-based company believes blood-based tests are the future of cancer screening, while sales of its coronavirus testing solutions continue to surge
Shareholders and others will have the opportunity to engage with top management from Biocept, Starton Therapeutics, Todos Medical, and Gevo
Director Interviews
Todos Medical reveals positive clinical proof of concept data from its rapid coronavirus test
Director Interviews
Todos Medical growing the business with COVID-19 testing sales heading into the winter months
